ffb.ca
About ffb.ca
January 18, 2010 - The Foundation Fighting Blindness (FFB) is proud to announce that Dr. Robert Koenekoop of McGill University is now recruiting Leber congenital amaurosis (LCA) patients with specific gene defects in RPE65 and LRAT for a drug trial to test the safety and efficacy of a new retinoid. This trial is approved by Health Canada (TPD) and McGill University Health Centre at the Montreal Children's Hospital.
